Bikul Das
Overview
Explore the profile of Bikul Das including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hypoxia-driven mobilization of altruistic cancer stem cells in platinum-treated head and neck cancer
Pathak L, Pal B, Talukdar J, Saikia P, Sandhya S, Tasabehji W, et al.
Front Immunol
. 2025 Feb;
15:1336882.
PMID: 39963656
Background: Head and neck cancers harbor dormant cancer stem cells (CSCs). This study explores how platinum therapy impacts these cells in a non-genetic manner and the role of hypoxia in...
2.
Sandhya S, Talukdar J, Gogoi G, Dey K, Das B, Baishya D
Heliyon
. 2024 Apr;
10(8):e29385.
PMID: 38665592
This study aimed at analysing the effects of coconut ( L.) kernel extract (CKE) on oxidative stress, C-MYC proto-oncogene, and tumour formation in a skin cancer model. Tumorigenesis was induced...
3.
Saikia P, Pathak L, Mitra S, Das B
Front Immunol
. 2023 Nov;
14:1198269.
PMID: 37954619
Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy among the Head and Neck cancer. OSCCs are highly inflammatory, immune-suppressive, and aggressive tumors. Recent sequencing based studies demonstrated the...
4.
Bhuyan S, Pal B, Pathak L, Saikia P, Mitra S, Gayan S, et al.
Front Immunol
. 2022 Oct;
13:933329.
PMID: 36248858
Tumor hypoxia and oxidative stress reprograms cancer stem cells (CSCs) to a highly aggressive and inflammatory phenotypic state of tumor stemness. Previously, we characterized tumor stemness phenotype in the ATP...
5.
Bayat Mokhtari R, Qorri B, Baluch N, Sparaneo A, Fabrizio F, Muscarella L, et al.
Oncotarget
. 2022 Sep;
13:968-969.
PMID: 36093295
[This corrects the article DOI: 10.18632/oncotarget.28011.].
6.
Bayat Mokhtari R, Qorri B, Baluch N, Sparaneo A, Fabrizio F, Muscarella L, et al.
Oncotarget
. 2021 Jul;
12(15):1470-1489.
PMID: 34316328
Objective: Aberrations in the PI3K/AKT/mTOR survival pathway in many cancers are the most common genomic abnormalities. The phytochemical and bioactive agent sulforaphane (SFN) has nutrigenomic potential in activating the expression...
7.
Bayat Mokhtari R, Sambi M, Qorri B, Baluch N, Ashayeri N, Kumar S, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298809
Cancer immunotherapy harnesses the immune system by targeting tumor cells that express antigens recognized by immune system cells, thus leading to tumor rejection. These tumor-associated antigens include tumor-specific shared antigens,...
8.
Bayat Mokhtari R, Qorri B, Sambi M, Baluch N, Kumar S, Das B, et al.
Cancers (Basel)
. 2021 Jul;
13(11).
PMID: 34205080
Therapeutic targeting of stem cells needs to be strategically developed to control tumor growth and prevent metastatic burden successfully. Breast cancer presents a unique clinical problem because of the variety...
9.
Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sandhya S, et al.
Am J Pathol
. 2021 Apr;
191(7):1255-1268.
PMID: 33887214
We postulate that similar to bacteria, adult stem cells may also exhibit an altruistic defense mechanism to protect their niche against external threat. Herein, we report mesenchymal stem cell (MSC)-based...
10.
Pathak L, Das B
Front Immunol
. 2021 Feb;
11:594572.
PMID: 33584661
(), the causative organism of pulmonary tuberculosis (PTB) now infects more than half of the world population. The efficient transmission strategy of the pathogen includes first remaining dormant inside the...